|
Name |
3-[(6R,7R)-6-(2,4-dihydroxy-6-methylbenzoyl)oxy-7-methyl-8-oxo-1,5,6,7-tetrahydroisochromen-3-yl]propanoic acid
|
| Molecular Formula | C21H22O8 | |
| IUPAC Name* |
3-[(6R,7R)-6-(2,4-dihydroxy-6-methylbenzoyl)oxy-7-methyl-8-oxo-1,5,6,7-tetrahydroisochromen-3-yl]propanoic acid
|
|
| SMILES |
C[C@@H]1[C@@H](CC2=C(C1=O)COC(=C2)CCC(=O)O)OC(=O)C3=C(C=C(C=C3C)O)O
|
|
| InChI |
InChI=1S/C21H22O8/c1-10-5-13(22)8-16(23)19(10)21(27)29-17-7-12-6-14(3-4-18(24)25)28-9-15(12)20(26)11(17)2/h5-6,8,11,17,22-23H,3-4,7,9H2,1-2H3,(H,24,25)/t11-,17-/m1/s1
|
|
| InChIKey |
WNHGHSZOVRSLLA-PIGZYNQJSA-N
|
|
| Synonyms |
J3.616.322D
|
|
| CAS | NA | |
| PubChem CID | 132992078 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 402.4 | ALogp: | 2.3 |
| HBD: | 3 | HBA: | 8 |
| Rotatable Bonds: | 6 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 130.0 | Aromatic Rings: | 3 |
| Heavy Atoms: | 29 | QED Weighted: | 0.639 |
| Caco-2 Permeability: | -5.633 | MDCK Permeability: | 0.00001370 |
| Pgp-inhibitor: | 0 | Pgp-substrate: | 0.052 |
| Human Intestinal Absorption (HIA): | 0.047 | 20% Bioavailability (F20%): | 0.044 |
| 30% Bioavailability (F30%): | 0.014 |
| Blood-Brain-Barrier Penetration (BBB): | 0.013 | Plasma Protein Binding (PPB): | 96.45% |
| Volume Distribution (VD): | 0.282 | Fu: | 2.59% |
| CYP1A2-inhibitor: | 0.138 | CYP1A2-substrate: | 0.075 |
| CYP2C19-inhibitor: | 0.067 | CYP2C19-substrate: | 0.054 |
| CYP2C9-inhibitor: | 0.261 | CYP2C9-substrate: | 0.96 |
| CYP2D6-inhibitor: | 0.097 | CYP2D6-substrate: | 0.164 |
| CYP3A4-inhibitor: | 0.328 | CYP3A4-substrate: | 0.195 |
| Clearance (CL): | 10.076 | Half-life (T1/2): | 0.921 |
| hERG Blockers: | 0.041 | Human Hepatotoxicity (H-HT): | 0.759 |
| Drug-inuced Liver Injury (DILI): | 0.96 | AMES Toxicity: | 0.017 |
| Rat Oral Acute Toxicity: | 0.247 | Maximum Recommended Daily Dose: | 0.927 |
| Skin Sensitization: | 0.584 | Carcinogencity: | 0.614 |
| Eye Corrosion: | 0.026 | Eye Irritation: | 0.218 |
| Respiratory Toxicity: | 0.402 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC003837 | ![]() |
0.538 | D07MGA | ![]() |
0.273 | ||
| ENC003304 | ![]() |
0.509 | D06FVX | ![]() |
0.246 | ||
| ENC002132 | ![]() |
0.509 | D0S0LZ | ![]() |
0.226 | ||
| ENC002726 | ![]() |
0.505 | D0O1UZ | ![]() |
0.224 | ||
| ENC002211 | ![]() |
0.505 | D04AIT | ![]() |
0.223 | ||
| ENC003839 | ![]() |
0.500 | D0H0SJ | ![]() |
0.223 | ||
| ENC003449 | ![]() |
0.500 | D08LTU | ![]() |
0.221 | ||
| ENC003838 | ![]() |
0.500 | D0O6KE | ![]() |
0.220 | ||
| ENC002725 | ![]() |
0.477 | D0K8KX | ![]() |
0.219 | ||
| ENC002131 | ![]() |
0.477 | D01KKQ | ![]() |
0.219 | ||